Foresite Capital Management VI LLC — 13F Holdings

2026 Q3  ·  27 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, Foresite Capital Management VI LLC maintained a portfolio of 27 distinct positions. The most significant new addition was Korsana Biosciences, Inc., now representing 8.09% of the total fund value. They heavily accumulated shares in ArriVent BioPharma, Inc., increasing the position by 62.7%. Conversely, Foresite Capital Management VI LLC completely exited their position in Celldex Therapeutics, Inc..
Position History hover any row below to update
Loading…
PCA Score Concentration Risk
Risk ENB
Total Positions
27
Quarter
2026 Q3
Top Holding
CGON (26.4%)
Top 10 Concentration
77.7%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-27 of 27

Foresite Capital Management VI LLC Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
CGON
CG Oncology, In...
Healthcare 26.41% 26.20% #1
Prev: #1
6.5
—
-260,000 -11.0%
P
S
2,109,574 $149,547,701
$31.33 +152.0%
$70.89 +11.4%
2024 Q4 13F Filing 2026-09-30 2026-11-16
KRSA
Korsana Bioscie...
Healthcare 8.09% — #2
Prev: #—
8.2
—
1,431,660 —
NEW
1,431,660 $45,813,120 2026 Q3 13F Filing 2026-09-30 2026-11-16
LTGO
Latigo Biothera...
Healthcare 6.50% — #3
Prev: #—
7.1
—
2,203,800 —
NEW
2,203,800 $36,803,460 2026 Q3 13F Filing 2026-09-30 2026-11-16
SPTX
Seaport Therape...
Healthcare 6.34% 6.02% #4 1
Prev: #3
4.0
—
no change no change
P
S
1,779,521 $35,892,939 2026 Q2 13F Filing 2026-09-30 2026-11-16
DNLI
Denali Therapeu...
Healthcare 5.90% 5.59% #5 1
Prev: #4
4.9
—
221,000 15.8%
P
S
1,617,771 $33,439,327 2025 Q3 13F Filing 2026-09-30 2026-11-16
PBLS
Parabilis Medic...
Healthcare 5.70% 4.26% #6 2
Prev: #8
3.3
—
no change no change
P
S
999,044 $32,259,131 2026 Q2 13F Filing 2026-09-30 2026-11-16
ALMS
ALUMIS INC.
Healthcare 5.54% 18.60% #7 5
Prev: #2
3.2
—
no change no change
P
S
4,247,670 $31,390,281 2024 Q4 13F Filing 2026-09-30 2026-11-16
AGIO
AGIOS PHARMACEU...
Healthcare 4.86% 4.53% #8 2
Prev: #6
3.9
—
42,128 5.4%
P
S
827,128 $27,502,006 2025 Q4 13F Filing 2026-09-30 2026-11-16
VSTM
Verastem, Inc.
Healthcare 4.47% 1.87% #9 5
Prev: #14
2.8
—
no change no change
P
S
3,146,631 $25,330,380 2025 Q2 13F Filing 2026-09-30 2026-11-16
GHRS
GH Research PLC
Healthcare 3.90% 3.93% #10 1
Prev: #9
2.6
—
no change no change
P
S
940,493 $22,082,776 2026 Q1 13F Filing 2026-09-30 2026-11-16
CRVS
Corvus Pharmace...
Healthcare 3.72% 4.26% #11 4
Prev: #7
2.5
—
no change no change
P
S
1,831,233 $21,095,804 2024 Q4 13F Filing 2026-09-30 2026-11-16
KYMR
Kymera Therapeu...
Healthcare 2.89% 2.61% #12
Prev: #12
2.2
—
no change no change
P
S
146,332 $16,358,454 2024 Q4 13F Filing 2026-09-30 2026-11-16
AVBP
ArriVent BioPha...
Healthcare 2.62% 1.63% #13 4
Prev: #17
4.0
—
189,000 62.7%
P
S
490,341 $14,847,525 2026 Q2 13F Filing 2026-09-30 2026-11-16
OBX
Obsidian Therap...
Healthcare 2.22% — #14
Prev: #—
4.4
—
916,063 —
NEW
916,063 $12,577,545 2026 Q3 13F Filing 2026-09-30 2026-11-16
JBIO
Jade Bioscience...
Healthcare 2.20% 3.07% #15 5
Prev: #10
1.9
—
no change no change
P
S
886,667 $12,457,671 2026 Q1 13F Filing 2026-09-30 2026-11-16
HNGE
Hinge Health, I...
Healthcare 1.86% 2.85% #16 5
Prev: #11
0.7
—
-112,300 -51.0%
P
S
108,100 $10,511,644 2025 Q2 13F Filing 2026-09-30 2026-11-16
AURA
Aura Bioscience...
Healthcare 1.48% 1.47% #17 1
Prev: #18
1.6
—
no change no change
P
S
1,333,334 $8,373,338 2026 Q2 13F Filing 2026-09-30 2026-11-16
BEAM
Beam Therapeuti...
Healthcare 1.42% 1.76% #18 3
Prev: #15
1.6
—
no change no change
P
S
330,000 $8,068,500 2026 Q2 13F Filing 2026-09-30 2026-11-16
ZURA
Zura Bio Ltd
Healthcare 1.29% 0.41% #19 2
Prev: #21
3.5
—
1,307,000 290.4%
P
S
1,757,000 $7,309,120 2026 Q1 13F Filing 2026-09-30 2026-11-16
NERV
Minerva Neurosc...
Healthcare 1.17% 1.71% #20 4
Prev: #16
1.5
—
no change no change
P
S
1,985,584 $6,651,706 2026 Q1 13F Filing 2026-09-30 2026-11-16
IRON
Disc Medicine, ...
Healthcare 0.79% 0.01% #21 2
Prev: #23
3.3
—
67,500 6958.8%
P
S
68,470 $4,482,046 2026 Q2 13F Filing 2026-09-30 2026-11-16
ENTX
Entera Bio Ltd.
Healthcare 0.63% — #22
Prev: #—
3.8
—
1,225,490 —
NEW
1,225,490 $3,566,176 2026 Q3 13F Filing 2026-09-30 2026-11-16
KLRA
Kailera Therape...
Healthcare 0.00% 0.13%
Sold All 😨
(Was: #22)
0.0
—
-37,500 -100.0%
CLOSED
— $— 2026 Q2 13F Filing 2026-09-30 2026-11-16
N/A
Research Allian...
Unknown 0.00% 0.50%
Sold All 😨
(Was: #20)
0.0
—
-300,000 -100.0%
CLOSED
— $— — 13F Filing 2026-09-30 2026-11-16
CRNX
Crinetics Pharm...
Healthcare 0.00% 1.23%
Sold All 😨
(Was: #19)
0.0
—
-212,010 -100.0%
CLOSED
— $— 2026 Q1 13F Filing 2026-09-30 2026-11-16
ATAI
AtaiBeckley Inc...
Healthcare 0.00% 2.26%
Sold All 😨
(Was: #13)
0.0
—
-2,750,000 -100.0%
CLOSED
— $— 2025 Q4 13F Filing 2026-09-30 2026-11-16
CLDX
Celldex Therape...
Healthcare 0.00% 5.09%
Sold All 😨
(Was: #5)
0.0
—
-879,713 -100.0%
CLOSED
— $— 2026 Q1 13F Filing 2026-09-30 2026-11-16
Showing 1-27 of 27 holdings

Unlock Full Foresite Capital Management VI LLC Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →